Literature DB >> 10984217

A new three-dimensional dose distribution reduction scheme for tubular organs.

S M Zhou1, L B Marks, G S Tracton, G S Sibley, K L Light, P D Maguire, M S Anscher.   

Abstract

In tubular structures, spatial aspects of the dose distribution may be important in determining the normal tissue response. Conventional dose-volume-histograms (DVHs) and dose-surface-histograms (DSHs) lack spatial information and may not be adequate to represent the three-dimensional (3D) dose data. A new 3D dose distribution data reduction scheme which preserves its longitudinal and circumferential character is presented. Dose distributions were generated at each axial level for esophagus or rectum in 123 patients with lung cancer or prostate cancer. Dose distribution histograms at each axial level were independently analyzed along the esophageal or rectal circumference to generate dose-circumference-histogram (DCH) sheets. Two types of plots were then generated from the DCH sheet. The first considered the percentage of the circumference at each axial level receiving various doses. The second considered the minimum dose delivered to any percentage of the circumference at each axial level. The DCH as a treatment planning tool can be easily implemented in a 3D planing system and is potentially useful for the study of the relationship between the complication risk and the longitudinal and circumferential dose distributions.

Entities:  

Mesh:

Year:  2000        PMID: 10984217     DOI: 10.1118/1.1287050

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  2 in total

1.  Dosimetric analysis and comparison of IMRT and HDR brachytherapy in treatment of localized prostate cancer.

Authors:  V Murali; P G G Kurup; P Mahadev; S Mahalakshmi
Journal:  J Med Phys       Date:  2010-04

2.  Analysis of esophageal-sparing treatment plans for patients with high-grade esophagitis.

Authors:  Joshua Niedzielski; Jaques B Bluett; Ryan T Williamson; Zhongxing Liao; Daniel R Gomez; Laurence E Court
Journal:  J Appl Clin Med Phys       Date:  2013-07-08       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.